Clinical trial
The Effect of Benralizumab on Lung Physiology, Exercise-induced Bronchoconstriction and General Health Status: an Exploratory Mechanistic Study
NCT03327701 is registered in ClinicalTrials.gov with Louis-Philippe Boulet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Benralizumab on Lung Physiology, Exercise-induced Bronchoconstriction and General Health Status: an Exploratory Mechanistic Study
- Lead sponsor
- Louis-Philippe Boulet
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- December 31, 2017
- Completion date
- April 30, 2020
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.